Diabetic ketoacidosis (DKA) is a major medical emergency where metabolic failure puts the patient’s life at extreme risk.
It’s characterized by hyperglycemia, ketonemia, and metabolic acidosis resulting from absolute or relative insulin deficiency combined with excess counter-regulatory hormones.
It occurs most commonly in people with type 1 diabetes but is increasingly seen in type 2 diabetes, particularly under stress.
DKA develops when the body cannot use glucose for energy and begins breaking down fat, producing ketones that acidify the blood. Without prompt intervention, it can lead to coma, organ failure, or death.
This article explores the early warning signs, underlying causes, and standard medical treatments for DKA.
Early Warning Signs
DKA often builds gradually over hours to a day, but can escalate rapidly once ketones accumulate. Recognizing the earliest signals is critical, especially for people with diabetes or those at risk.
One of the first and most noticeable symptoms is excessive thirst (polydipsia) accompanied by frequent urination (polyuria). High blood glucose levels cause the kidneys to excrete excess sugar, drawing out large amounts of water and leading to dehydration.
Patients may notice their urine output doubles or triples while feeling constantly parched, even after drinking fluids. This fluid loss can quickly reach several liters per day, exacerbating the cycle. They also report fatigue, blurred vision, and general weakness as blood glucose climbs above 250 mg/dL.
As ketosis and acidosis develop, gastrointestinal symptoms, such as nausea, vomiting, and diffuse abdominal pain, emerge. Vomiting exacerbates dehydration and electrolyte loss.
Notably, the American Diabetes Association reveals that about 10% of cases are euglycemic DKA (glucose <200 mg/dL). Symptoms remain similar but without marked hyperglycemia, delaying diagnosis.
The Underlying Causes
At its core, DKA results from absolute or relative insulin deficiency combined with elevated counter-regulatory hormones such as glucagon, cortisol, catecholamines, and growth hormone.
These hormones drive gluconeogenesis and lipolysis, flooding the bloodstream with glucose and free fatty acids that the liver converts into ketones. The resulting acidosis and osmotic diuresis create a vicious cycle of dehydration, electrolyte imbalances (especially potassium shifts), and worsening metabolic derangement.
Substance use disorders also exacerbate poor glycemic control, leading to DKA. If substance use disorder is responsible for DKA, medical detoxification at a detox and rehab center is important. Purpose Healing Center notes that this process involves using medications to help with the discomfort of withdrawal and avoid medical problems during detox.
Medical detoxification is expensive, but Medicaid can make it affordable. In Phoenix, Arizona, for instance, there are 235 centers. Of them, only 83 provide Medicaid detox and rehab in Phoenix.
Arizona Health Care Cost Containment System (AHCCCS) is Arizona’s Medicaid. Beyond Phoenix, Medicaid is administered through AHCCCS in all cities of the state.
Medicaid often covers inpatient and outpatient detox programs, medications for withdrawal symptoms, and counseling and follow-up care.
Even in Scottsdale, out of 342 centers, only 161 accept Medicaid. Finding an accredited Scottsdale treatment center is key to stabilizing both blood sugar and sobriety.
Standard Protocols for Medical Treatment
Management of DKA adheres to the 2024 American Diabetes Association (ADA) consensus and updated 2026 Standards of Care. The primary clinical priorities include fluid resuscitation, insulin therapy, electrolyte correction, and addressing underlying precipitants.
The goal is to correct volume depletion, suppress ketogenesis, resolve acidosis, and prevent complications like cerebral edema or hypokalemia.
Diagnosis confirmation relies on a clinical triad of high glucose, ketonemia, and metabolic acidosis.
Disease severity guides the intensity of medical intervention. Mild DKA presents with a pH between 7.25 and 7.30. Moderate DKA is characterized by a pH between 7.00 and 7.24. Severe DKA involves a pH below 7.00 or altered mental status.
Fluid therapy is given immediately, with 15 to 20 mL/kg/hour of 0.9% normal saline or balanced crystalloids for the first 1 to 2 hours to restore intravascular volume.
The next step is to switch to 0.45% saline once hemodynamically stable, adding 5 to 10% dextrose when glucose falls below 200 to 250 mg/dL to prevent hypoglycemia while continuing insulin. Total deficit (often 6 to 10 L) corrects over 24 to 48 hours, avoiding rapid osmolality drops.
Insulin therapy follows fluids and a potassium check. Continuous IV regular insulin infusion at 0.1 units/kg/hour (no initial bolus if potassium adequate) suppresses ketogenesis.
Electrolyte replacement is critical. Add 20 to 30 mEq/L of potassium to fluids once <5.2 mEq/L; target 4 to 5 mEq/L (total body deficit ~3 to 5 mEq/kg). Monitor every 2 to 4 hours.
Frequently Asked Questions
Can DKA occur in people with type 2 diabetes?
Yes. While DKA is more common in type 1 diabetes, it is increasingly seen in type 2 diabetes, especially during illness, infection, surgery, or severe stress.
How can I prevent DKA if I have diabetes?
Prevention focuses on never skipping insulin, monitoring blood glucose regularly, especially during illness, and checking for ketones when glucose is >250 mg/dL.
Is euglycemic DKA more dangerous than regular DKA?
Not necessarily more dangerous, but it is often diagnosed later because blood sugar isn’t extremely high. This can delay treatment. Anyone with diabetes experiencing nausea, vomiting, abdominal pain, shortness of breath, or fatigue should test ketones even if glucose levels appear normal.
Key Statistics
| Euglycemic DKA | ~10% of cases | Glucose <200 mg/dL; symptoms similar but diagnosis often delayed |
| Blood Glucose Threshold | Symptoms often appear >250 mg/dL | Polydipsia, polyuria, fatigue, blurred vision |
| DKA Severity Classification | • Mild: pH 7.25–7.30 • Moderate: pH 7.00–7.24 • Severe: pH <7.00 or altered mental status | Based on arterial pH and mental status |
| Potassium Management | • Add 20–30 mEq/L once serum K+ <5.2 mEq/L • Target: 4–5 mEq/L • Total body deficit: ~3–5 mEq/kg | Monitor every 2–4 hours |
| Dextrose Addition | 5–10% dextrose when glucose <200–250 mg/dL | To prevent hypoglycemia while continuing insulin |
Diabetic ketoacidosis illustrates both the fragility and resilience of metabolic balance. Healthcare teams can reverse this emergency effectively if they recognize early warning signs and follow the standard protocols for medical treatment.
Ongoing patient education and vigilant monitoring remain the best defenses against this serious complication. With awareness and timely action, lives are saved, and the burden of DKA is significantly reduced.
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
